DGT: Pneumothorax: indication and technique {#j_iss-2018-2008_s_001}
===========================================

The burden between undersupply and overtreatment in the care of primary spontaneous pneumothorax {#j_iss-2018-2008_s_001_s_001}
------------------------------------------------------------------------------------------------

(Abstract ID: 23)

M. Ried^1^, T. Suttner^1^, R. Neu^1^, T. Potzger^1^, C. Großer^1^, T. Szöke^1^, H.-S. Hofmann^1^

^1^*Universitätsklinikum Regensburg*

**Background:**

The optimal therapy of primary spontaneous pneumothorax (PSP) is still controversial and varies from conservative to surgical treatment strategies. However, a high first recurrence rate of approximately 30-50% is reported after conservative therapy. The purpose of this study was to analyze the incidence of recurrence with its recurrence-free time and to identify potential risk factors for recurrence after PSP.

**Materials and methods:**

Retrospective analysis of 135 patients with PSP, who were treated either conservatively with a chest tube (n= 87) or surgical with Video-assisted Thoracoscopic Surgery (VATS; n= 48) between January 2008 through December 2012.

**Results:**

Included were 101 (74.8%) male and 34 (25.2%) female patients with a mean age of 35.7 years. There were no significant differences in age, gender, smoking history, body mass index, or size of the PSP among both groups. Indications for surgery included blebs/bullae in the radiological imaging (n=20), persistent air leak (n=15) or occupations/wishes of patients (n=13). A first ipsilateral recurrent pneumothorax (true recurrence) was observed in 31.1% of all patients (VATS: 6.25%; conservative: 44.8%). Including contralateral recurrence the overall first recurrence rate was 41.3% (VATS: 14.6%; conservative: 57.5%). The recurrence-free time did not differ significantly between both treatment groups (p=0.51) and most recurrences were observed within the first 6 months after PSP. Independent risk factors for first recurrence were conservative therapy (p=0.0001), size of PSP (conservative; p=0.016) and BMI \<17 (VATS; 0.022). The risk for second and third recurrence of PSP was 17.5% (n=10), respectively 70%, but 100% for both after conservative therapy.

**Conclusion:**

The indication for surgery of PSP should be made depending on the risk factors and the patient\'s wishes, in order to prevent first recurrences but also an overtreatment. Therapy of first and following PSP recurrences should be with surgery since conservative treatment is associated with a 100% recurrence rate.
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**Background:**

Liposarcomas are the second most common soft tissue sarcomas in adults after malignant fibrous histiocytomas and usually occur in the lower extremities and the retroperitoneum. Primary liposarcomas in the mediastinum are very rare and represent less than 1% of all mediastinal malignancies. We present a case of 73 year old patient with a well differentiated intrathoracic liposarcoma.

**Materials and methods:**

The patient was admitted to the hospital for further diagnosis of of an unclear dyspnea symtomatic, weight loss and malaise. In a chest-x-ray a large paracardial mass was detected in the right anterior mediastinum which was progredient in size compared to a chest-x-ray four years ago. CT-scan describes an approximately 13 cm large lipoma in the paracardial right anterior mediastinum. However the radiological results couldn\'t exclude malignancy of the tumour . Therefore surgical resection of the tumour was indicated.

**Results:**

The tumour that macroscopically presented as a lipoma was endoscopically resected by a video assisted right thoracoscopy (VATS). The tumour extension ranged from the vena anonyma to the diaphragm. Histologically a well differentiated liposarcoma with 14 cm in size was diagnosed, confirmed by molecular examinations. 7 month after surgical resection the patient is in a good general condition and free from tumour.

**Conclusion:**

Considering the limited published data concerning the very rare intrathoracic liposarcomas complete surgical resection remains the most effective treatment. Radiotherapy and chemotherapy are believed to be ineffective therapeutic modalities. Surgical resection can be carried out in an open manner via a thoracotomy or endoscopically via VATS. Our case demonstrate that even large intrathoracic tumours can be complete resected endoscopically with the advantage of a good visualization.
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**Background:**

Pulmonary metastasectomy has a more than 130 years lasting tradition. Over the last decades, evidence had been mainly influenced by the results from the International Registry of Lung Metastases (IRLM), reporting on 5,206 patients with different carcinomas or non-epithelial tumors. Despite encouraging results, the role of lung metastasectomy in treatment of various cancers remained and is still controversial. In this systematic review, we analyzed the current evidence of lung metastasectomy for patients with colorectal cancer, breast cancer, renal cell cancer, head and neck cancer, malignant melanoma, soft tissue sarcoma and osteosarcoma.

**Materials and methods:**

We performed a structured literature research on 01.10.2017 in Medline and the Cochrane Database of Systematic Reviews. We included articles published since 01.01.2010. We also considered articles published since 01.01.2000 for primary cancers other than colorectal carcinoma or sarcoma due to the limited amount of publications. All articles containing information on the perioperative period and post-metastasectomy survival (PMS) of at least 20 patients were included. We increased this threshold for colorectal carcinoma to at least 100 participants because of the high number of available studies. We judged the quality of evidence according to the „Levels of Evidence" (LoE) from the University of Oxford.

**Results:**

The search strategy led to 10,004 articles. Of these, we included 95 trials reporting on 11,994 patients with different primary cancers undergoing pulmonary metastasectomy. Indication criteria for lung metastasectomy were resected primary cancer, feasibility of complete resection and mainly no evidence for extrathoracic metastases. Patients with primary colorectal cancer reached a median PMS of 17 to 55 months and 5-year survival rates of 40 to 82% (N=16 trials, 5,097 patients, LoE 4). Lung metastasectomy led to a median PMS of 32 to 97 months and 5-year survival rates of 31 to 54% in patients with successfully resected primary breast cancer (N=11 trials, 1,023 patients, LoE 4). In the subset of patients with renal cell cancer, pulmonary resection resulted in 5-year survival rates of 33 to 60% and a median PMS of 30 to 94 months (N=16 trials, 1,517 patients, LoE 4). Statistical analysis revealed that patients with primary head and neck cancer showed a median PMS of 9.5 to 77 months and 5-year survival rates of 0 to 59% (N=17, 695 patients, LoE 4). Patients with malignant melanoma reached a median PMS of 17 to 52 months and 5-year survival rates of 18 to 37% (N=11 trials, 1,376 patients, LoE 4). Pulmonary resection of lung lesions from soft tissue sarcoma or osteosarcoma resulted in a median PMS of 8.8 to 79.5 months and 5-year survival rates of 21.7 to 58.4% (N=24 trials, 2,286 patients, LoE 4). Overall, non-anatomical resection was the predominant resection method and thoracotomy the most frequently used surgical approach.

**Conclusion:**

In patients with pulmonary metastatic colorectal cancer metastasectomy is already the treatment of choice, even after successful resection of liver metastases. On the basis of current evidence and encouraging results, each patient with isolated pulmonary metastases and controlled other primary cancer should be presented in an interdisciplinary tumor conference containing a thoracic surgeon to evaluate applicability of lung metastasectomy.
